Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohn's Disease

Clinical trial NCT00353756 · UNKNOWN

Trial details

NCT number: NCT00353756
Sponsor: Avidia
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2006-09-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.